1992
DOI: 10.1016/s0021-9258(19)49617-8
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of the relative movement of actin and myosin by caldesmon and calponin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
31
0

Year Published

1995
1995
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 168 publications
(32 citation statements)
references
References 41 publications
1
31
0
Order By: Relevance
“…As for ␣-SMA, the decline starts in the interventricular septum, extends first toward the left ventricular free wall and then to the right ventricular free wall, and only then to the trabeculae. manner (Shirinsky et al, 1992;Haeberle and Hemric, 1994). After ED14, the coexpression of ␣and ␤-MHC disappears and the expression of calponin and ␣-SMA begins to decline (Figs.…”
Section: The Transition Of the Embryonic Into The Definitive Myocardiummentioning
confidence: 95%
See 1 more Smart Citation
“…As for ␣-SMA, the decline starts in the interventricular septum, extends first toward the left ventricular free wall and then to the right ventricular free wall, and only then to the trabeculae. manner (Shirinsky et al, 1992;Haeberle and Hemric, 1994). After ED14, the coexpression of ␣and ␤-MHC disappears and the expression of calponin and ␣-SMA begins to decline (Figs.…”
Section: The Transition Of the Embryonic Into The Definitive Myocardiummentioning
confidence: 95%
“…The temporary expression of the thinfilament protein ␣-smooth-muscle actin (␣-SMA) in the cardiomyocytes of the embryonic heart of rat and chicken (Sugi and Lough, 1992;Ruzicka and Schwartz, 1988;Woodcock-Mitchell et al, 1988;Sawtell and Lessard, 1989), therefore, prompted us to investigate whether the coexpression of ␣and ␤-myosin heavy chain (MHC) that is typical of the earliest phases of cardiomyocyte development is correlated with the expression of smooth-muscle proteins, and, if so, what this combination of phenotypic markers reveals about cardiomyocyte development. In this study, we investigated the spatiotemporal pattern of expression of ␣-SMA and the thin filament-binding proteins calponin and caldesmon (Shirinsky et al, 1992;Haeberle and Hemric, 1994;Gerthoffer and Pohl, 1994), and observed, indeed, a correlation in the expression of ␣-SMA and calponin, the troponin I/T-like molecule of smooth muscle, with the coexpression of both MHCs. Based on the electron microscopic data available in the literature, we argue that ␣-SMA expression is a very useful light microscope marker to follow the transition from the random arrangement of myofibrils in the embryonic heart to the highly ordered organization in the fetal heart; that is to say, to follow the myofibrillar maturation in the prenatal rat heart.…”
mentioning
confidence: 93%
“…Calponin has been proposed to have a role in the cytoskeleton possibly via cross-linking actin and intermediate filaments (230,605). Calponin inhibits filament sliding in in vitro motility assay (70,248,308,589) and inhibits contraction in smooth muscle preparations (308,510), which shows that it also can influence the contractile system directly. Interestingly, calponin seems to mainly influence the V max (308,510).…”
Section: A Regulation Of Contractile Proteinsmentioning
confidence: 99%
“…Calponin is a 32-36-kDa actin-binding protein found first in smooth muscle (Takahashi et al, 1986) and select nonmuscle tissues (reviewed in Chalovich and Pfitzer, 1997). Calponin has properties that indicate it may regulate muscle contraction, including the ability to inhibit actomyosin ATPase activity (Winder and Walsh, 1990), force production in muscle fiber preparations (Itoh et al, 1994), and movement in the in vitro motility assay (Shirinsky et al, 1992;Haeberle, 1994). However, other observations suggest that calponin is a structural protein.…”
Section: Introductionmentioning
confidence: 99%